Ramsay Générale de Santé SA (GDS.PA)
EUR 9.68
(-0.41%)
EUR 9.68
(-0.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.9 Billion EUR | -50.82% |
| 2022 | 3.86 Billion EUR | 3.57% |
| 2021 | 3.73 Billion EUR | 3.35% |
| 2020 | 3.61 Billion EUR | -2.44% |
| 2019 | 3.7 Billion EUR | 89.44% |
| 2018 | 1.95 Billion EUR | 63.54% |
| 2017 | 1.19 Billion EUR | 8.71% |
| 2016 | 1.09 Billion EUR | -0.92% |
| 2015 | 1.11 Billion EUR | 37.56% |
| 2014 | 806.9 Million EUR | 394.42% |
| 2013 | 163.2 Million EUR | -73.68% |
| 2012 | 620.1 Million EUR | -9.88% |
| 2011 | 688.1 Million EUR | -9.01% |
| 2010 | 756.2 Million EUR | 7.66% |
| 2009 | 702.4 Million EUR | -17.08% |
| 2008 | 847.1 Million EUR | -8.25% |
| 2007 | 923.3 Million EUR | 224.88% |
| 2006 | 284.2 Million EUR | -36.42% |
| 2005 | 447 Million EUR | 12.37% |
| 2004 | 397.8 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 1.9 Billion EUR | -50.75% |
| 2023 Q2 | 1.9 Billion EUR | -50.2% |
| 2023 Q3 | 1.87 Billion EUR | -1.34% |
| 2023 Q4 | 1.9 Billion EUR | 1.37% |
| 2023 Q1 | 3.81 Billion EUR | -1.26% |
| 2022 Q2 | 3.89 Billion EUR | 1.24% |
| 2022 Q3 | 3.82 Billion EUR | -1.99% |
| 2022 Q4 | 3.86 Billion EUR | 1.21% |
| 2022 FY | 3.86 Billion EUR | 3.57% |
| 2022 Q1 | 3.85 Billion EUR | 3.13% |
| 2021 FY | 3.73 Billion EUR | 3.35% |
| 2021 Q1 | 3.65 Billion EUR | 1.02% |
| 2021 Q4 | 3.73 Billion EUR | 1.33% |
| 2021 Q2 | 3.65 Billion EUR | 0.0% |
| 2021 Q3 | 3.68 Billion EUR | 0.97% |
| 2020 Q3 | 3.63 Billion EUR | -1.12% |
| 2020 Q1 | 3.67 Billion EUR | -0.8% |
| 2020 Q2 | 3.67 Billion EUR | 0.0% |
| 2020 Q4 | 3.61 Billion EUR | -0.54% |
| 2020 FY | 3.61 Billion EUR | -2.44% |
| 2019 Q2 | 3.71 Billion EUR | 0.0% |
| 2019 FY | 3.7 Billion EUR | 89.44% |
| 2019 Q1 | 3.71 Billion EUR | 90.22% |
| 2019 Q3 | 3.72 Billion EUR | 0.21% |
| 2019 Q4 | 3.7 Billion EUR | -0.61% |
| 2018 FY | 1.95 Billion EUR | 63.54% |
| 2018 Q4 | 1.95 Billion EUR | -1.12% |
| 2018 Q3 | 1.97 Billion EUR | 31.7% |
| 2018 Q2 | 1.5 Billion EUR | 0.0% |
| 2018 Q1 | 1.5 Billion EUR | 25.59% |
| 2017 Q1 | 1.09 Billion EUR | -0.01% |
| 2017 Q4 | 1.19 Billion EUR | -0.58% |
| 2017 Q3 | 1.2 Billion EUR | 9.36% |
| 2017 Q2 | 1.09 Billion EUR | 0.0% |
| 2017 FY | 1.19 Billion EUR | 8.71% |
| 2016 FY | 1.09 Billion EUR | -0.92% |
| 2016 Q4 | 1.09 Billion EUR | -0.69% |
| 2016 Q3 | 1.1 Billion EUR | 0.0% |
| 2016 Q2 | 1.1 Billion EUR | 0.0% |
| 2016 Q1 | 1.1 Billion EUR | -0.23% |
| 2015 FY | 1.11 Billion EUR | 37.56% |
| 2015 Q2 | 1.07 Billion EUR | 0.0% |
| 2015 Q3 | 1.12 Billion EUR | 5.2% |
| 2015 Q4 | 1.11 Billion EUR | -1.46% |
| 2015 Q1 | 1.07 Billion EUR | 0.0% |
| 2014 Q2 | 812.7 Million EUR | 382.6% |
| 2014 Q1 | 168.4 Million EUR | 11.75% |
| 2014 FY | 806.9 Million EUR | 394.42% |
| 2013 Q2 | 163.2 Million EUR | -75.44% |
| 2013 Q1 | 664.5 Million EUR | 14.35% |
| 2013 FY | 163.2 Million EUR | -73.68% |
| 2013 Q4 | 150.7 Million EUR | -4.2% |
| 2013 Q3 | 157.3 Million EUR | -3.62% |
| 2012 FY | 620.1 Million EUR | -9.88% |
| 2012 Q2 | 620.1 Million EUR | -4.59% |
| 2012 Q1 | 649.9 Million EUR | -0.76% |
| 2012 Q4 | 581.1 Million EUR | -5.13% |
| 2012 Q3 | 612.5 Million EUR | -1.23% |
| 2011 Q1 | 710.7 Million EUR | -1.51% |
| 2011 Q4 | 654.9 Million EUR | -4.53% |
| 2011 Q3 | 686 Million EUR | -0.31% |
| 2011 FY | 688.1 Million EUR | -9.01% |
| 2011 Q2 | 688.1 Million EUR | -3.18% |
| 2010 FY | 756.2 Million EUR | 7.66% |
| 2010 Q4 | 721.6 Million EUR | -3.48% |
| 2010 Q3 | 747.6 Million EUR | -1.14% |
| 2010 Q2 | 756.2 Million EUR | -3.56% |
| 2010 Q1 | 784.1 Million EUR | 0.0% |
| 2009 Q2 | 702.4 Million EUR | 0.0% |
| 2009 FY | 702.4 Million EUR | -17.08% |
| 2008 FY | 847.1 Million EUR | -8.25% |
| 2007 FY | 923.3 Million EUR | 224.88% |
| 2006 FY | 284.2 Million EUR | -36.42% |
| 2005 FY | 447 Million EUR | 12.37% |
| 2004 FY | 397.8 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Clariane SE | 7.1 Billion EUR | 73.221% |
| LNA Santé SA | 341.16 Million EUR | -457.65% |